Paper8941983
Assimilation of oxalate, acetate, and CO2 by Oxalobacter formigenes.
Cornick NA and 1 other. Can J Microbiol, 1996. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Assimilation of oxalate, acetate, and CO2 by Oxalobacter formigenes. Papers, record 8941983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8941983
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetates | Major topic |
| Carbon Dioxide | Major topic |
| Formates | Major topic |
| Gram-Negative Anaerobic Bacteria | Major topic |
| Oxalates | Major topic |
| Acetyl Coenzyme A | |
| Amino Acids | |
| Biomass | |
| Cell Extracts | |
| Chromatography, High Pressure Liquid | |
| Citric Acid Cycle | |
| Culture Media | |
| Dicarboxylic Acids |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39379461 | Secondary products and molecular mechanism of calcium oxalate degradation by the strain Azospirillum sp. OX-1. | Sci Rep | 2024 | https://conductscience.org/library/papers/39379461 | PubMed |
| 36620050 | New perspectives on an old grouping: The genomic and phenotypic variability of Oxalobacter formigenes and the implications for calcium oxalate stone prevention. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36620050 | PubMed |
| 34485420 | Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34485420 | PubMed |
| 34190610 | Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist. | Appl Environ Microbiol | 2021 | https://conductscience.org/library/papers/34190610 | PubMed |
| 33769280 | Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease. | Elife | 2021 | https://conductscience.org/library/papers/33769280 | PubMed |
| 33376261 | Current update and future directions on gut microbiome and nephrolithiasis. | Indian J Urol | 2020 | https://conductscience.org/library/papers/33376261 | PubMed |
| 33129264 | Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition. | BMC Microbiol | 2020 | https://conductscience.org/library/papers/33129264 | PubMed |
| 30679485 | Comparative prevalence of Oxalobacter formigenes in three human populations. | Sci Rep | 2019 | https://conductscience.org/library/papers/30679485 | PubMed |
| 23632911 | The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. | Urolithiasis | 2013 | https://conductscience.org/library/papers/23632911 | PubMed |
| 22493020 | Oxalyl-coenzyme A reduction to glyoxylate is the preferred route of oxalate assimilation in Methylobacterium extorquens AM1. | J Bacteriol | 2012 | https://conductscience.org/library/papers/22493020 | PubMed |
| 20956531 | Identification and characterization of oxalate oxidoreductase, a novel thiamine pyrophosphate-dependent 2-oxoacid oxidoreductase that enables anaerobic growth on oxalate. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20956531 | PubMed |
| 19642417 | The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-mDM2 protein-protein interaction. | Nat Prod Rep | 2009 | https://conductscience.org/library/papers/19642417 | PubMed |
| 18245280 | Differential substrate specificity and kinetic behavior of Escherichia coli YfdW and Oxalobacter formigenes formyl coenzyme A transferase. | J Bacteriol | 2008 | https://conductscience.org/library/papers/18245280 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CS | 1431 | PubTator's text mining | https://conductscience.org/library/genes/1431 | NCBI Gene |
| ME2 | 4200 | PubTator's text mining | https://conductscience.org/library/genes/4200 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8941983
GET https://conductscience.org/api/papers/v1/8941983/authors